Identification and analysis of tumor-reactive CTLs in ovarian and cervical cancer tissues for developing a personalized immunotherapy

被引：1
|
作者：
Nosaka, Kazuto [1 ]
Yoshikawa, Yoshiaki [1 ]
Suzuki, Toshihiro [1 ]
Saito, Keigo [1 ]
Shimomura, Manami [1 ]
Mizuno, Shoichi [1 ]
Suzuki, Shiro [2 ]
Kikkawa, Fumitaka [2 ]
Nakatsura, Tetsuya [1 ]
机构：
[1] Natl Canc Ctr, Kashiwa, Chiba, Japan
[2] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
来源：
CANCER IMMUNOLOGY RESEARCH | 2018年 / 6卷 / 09期
关键词：
D O I：
10.1158/2326-6074.TUMIMM17-B79
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B79
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Developing a personalized immunotherapy for lung cancer patients: Identification of tumor reactive CTLs
    Yoshikawa, Toshiaki
    Nosaka, Kazuto
    Suzuki, Toshihiro
    Saito, Keigo
    Shimomura, Manami
    Mizuno, Shoichi
    Suzuki, Yutaka
    Seki, Masahide
    Sakamoto, Hiromi
    Aoki, Kazunori
    Aokage, Keiju
    Tsuboi, Masahiro
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2018, 109 : 293 - 293
  • [2] IDENTIFICATION AND ACTIVATION OF TUMOR-REACTIVE CELLS FOR ADOPTIVE IMMUNOTHERAPY
    TRIOZZI, PL
    STEM CELLS, 1993, 11 (03) : 204 - 211
  • [3] Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer
    Gerçel-Taylor, Ç
    Bazzett, LB
    Taylor, DD
    GYNECOLOGIC ONCOLOGY, 2001, 81 (01) : 71 - 76
  • [4] Tumor-reactive immunoglobulins in ovarian cancer: Diagnostic and therapeutic significance? (Review)
    Taylor, DD
    Gercel-Taylor, C
    ONCOLOGY REPORTS, 1998, 5 (06) : 1519 - 1524
  • [5] Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy
    Meraviglia, S.
    Caccamo, N.
    Guggino, G.
    Tolomeo, M.
    Siragusa, S.
    Stassi, G.
    Dieli, F.
    CURRENT MOLECULAR MEDICINE, 2010, 10 (08) : 719 - 726
  • [6] Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer
    Taylor, Douglas D.
    Gercel-Taylor, Cicek
    Parker, Lynn P.
    GYNECOLOGIC ONCOLOGY, 2023, 175 : 193 - 193
  • [7] Identification and enrichment for rare naturally occurring tumor-reactive T cells in the tumor microenvironment reveals new and diverse opportunities for cancer immunotherapy
    Powell, Daniel J., Jr.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [8] Cancer-driven exhaustion of tumor-reactive γδ-T cells: Relevance to immunosurveillance and immunotherapy
    Beck, Benjamin H.
    Kim, Hyung-Gyoon
    Haines, Hilary
    Feeley, Kyle
    Lopez, Richard
    CANCER RESEARCH, 2010, 70
  • [9] PROSTATE CANCER IMMUNOTHERAPY USING BI-SPECIFIC TUMOR-REACTIVE T CELLS
    Chan, Robert
    Leen, Ann
    Brenner, Malcolm
    Palapattu, Ganesh
    Vera, Juan
    JOURNAL OF UROLOGY, 2012, 187 (04): : E530 - E530
  • [10] Adoptive immunotherapy of cancer with hyper-expanded tumor-reactive T cells.
    Plautz, GE
    Wang, LX
    BLOOD, 2003, 102 (11) : 407B - 407B
12345